The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes

@article{Lindauer1998TheMB,
  title={The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes},
  author={Markus Lindauer and Thomas Stanislawski and Annett H{\"a}ussler and Edith Antunes and Anne Cellary and Christoph Huber and Matthias Theobald},
  journal={Journal of Molecular Medicine},
  year={1998},
  volume={76},
  pages={32-47}
}
 The disappointing clinical results of cancer immunotherapy of the past few decades have not diminished the optimism about the potential of the new generation of immunotherapeutic strategies towards treatment of malignant disease. Tremendous progress has been made over recent years in unveiling the molecular basis of antigen presentation and recognition by cytotoxic T lymphocytes (CTL). The molecular concepts that have emerged from these studies have led to the design of novel anticancer… CONTINUE READING